2025 annual financial data
Coya Therapeutics 2025 Net margin
Direct answer
Net margin was -267.14%.
Operating income was -20,265,623 USD and net income was -21,226,107 USD.
Operating cash flow was -10,739,301 USD.
Get free Coya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,945,753 USD
- Operating income
- -20,265,623 USD
- Net income
- -21,226,107 USD
- Operating cash flow
- -10,739,301 USD